Upstate Active Clinical Trials
Study Title:A Phase 3 Open Label Study to Evaluate the Long-term Safety and Tolerability of ALKS 8700 in Adults with Relapsing Remitting Multiple Sclerosis
What is the purpose of the study?The purpose of this research study is to test the long-term safety and treatment effect of ALKS 8700 in subjects who have relapsing-remitting MS.
Upstate Institutional Review Board (IRB) Number:1032689
Study Phase:Phase III
Patient Age Group:Adults
Principal Investigator:Corey A McGraw
Who can I contact for more information?
Name: Muhammad M Iqbal